News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current RCE market cap is 115.09M. The company's latest EPS is AUD -0.0642 and P/E is -8.72.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 680k | 1.12M | 1.86M | 3.09M | 4.37M |
| Operating Income | -2.74M | -4.29M | -13.61M | -11.06M | -12.96M |
| Net Income | -2.79M | -4.32M | -13.51M | -10.99M | -13.08M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 922k | 3.24M | 21.68M | 12.62M | 2.56M |
| Total Liabilities | 1.33M | 931k | 1.18M | 2.56M | 5.15M |
| Total Equity | -406k | 2.31M | 20.5M | 10.06M | -2.59M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -2.61M | -3.81M | -7.86M | -9.01M | -12.69M |
| Investing | -90k | -6k | -76k | -40k | -39k |
| Financing | 2.43M | 6.09M | 26.12M | -240k | 2.71M |
| Market Cap | 115.09M |
| Price to Earnings Ratio | -8.72 |
| Price to Sales Ratio | 26.17 |
| Price to Cash Ratio | 72.73 |
| Price to Book Ratio | -44.06 |
| Dividend Yield | - |
| Shares Outstanding | 203.7M |
| Average Volume (1 week) | 101.06k |
| Average Volume (1 Month) | 85.19k |
| 52 Week Change | -4.24% |
| 52 Week High | 0.785 |
| 52 Week Low | 0.41 |
| Spread (Intraday) | 0.01 (1.75%) |
| Company Name | Recce Pharmaceuticals Ltd |
| Address |
suite 10 perth, western australia 2000 |
| Website | https://www.recce.com.au |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
